Navigation Links
Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
Date:4/29/2008

ce sector. Specifically this office will provide our firm and our investee companies access to people, intellectual property, partnering and exit opportunities, syndication capital and deal flow," said Aidan King, Fountain's New York based partner.

Speaking at the launch of the fund, Minister for Enterprise, Trade and Employment, Micheál Martin T.D, said " A dynamic and healthy venture capital market is a prerequisite for the growth and development of high potential start-up companies in Ireland. I am delighted to announce the establishment of Fountain Healthcare Partners I, the fourth fund to be established under the Enterprise Ireland Seed and Venture Capital Scheme 2007-2012."

"The life science, healthcare and pharmaceutical sectors are key sectors in the Irish economy employing over 40,000 people in Ireland. The Fountain Fund is therefore very significant given its size and its focus on the life sciences sector." he added.

Fountain is a product-focused VC fund and will invest in companies with product development programmes that have a defined pathway to commercialisation, value enhancement and exit. The principals will take an active role with investees and will bring considerable industry expertise and a deep network of contacts in the US, Europe and Asia to investee companies.

The Fund will invest EUR0.5m to EUR7.0 million per company and will have an emphasis on the following sub-sectors: specialty pharmaceuticals , biotechnology, medical devices and diagnostics. Fountain will invest this capital over multiple funding rounds alongside international and domestic life science focused VC firms.

Fountain's investment premise holds that the global lifescience sector dynamics are currently very favourable for smaller venture backed private companies. Fountain also maintains that the Irish life science industry is at a turning point and has been underserved from a VC perspective.

- Ireland is Europe's most established locat
'/>"/>

SOURCE Fountain Healthcare Partners
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch
2. Pathwork(R) Diagnostics Launches Genomics-Based Test For Hard-To-Identify Tumors Through Its CLIA-Certified Laboratory
3. The Lustgarten Foundation for Pancreatic Cancer Research Launches New Public Service Announcement Featuring Last Lecturer Dr. Randy Pausch
4. Hovione Launches New Website
5. International Council on Nanotechnology launches global research needs assessment
6. Sigma(R) Launches Innovative ChIP Kit Technology For Epigenetic Research
7. Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R)
8. Botaneco Announces Launch of Second Generation Oleosome Product
9. Novagali Pharma Announces the Launch of Cationorm(R)
10. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
11. Cellix Ltd. Launches VenaEC Biochip for Flow-based Cell-adhesion Assays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... /PRNewswire/ -- Capitalizing on the ... and an active venture capital market, leaders from ... Retirement Fund, Indiana University, Purdue University, the University ... Credit Suisse today announced the establishment of the ... of funds. ,, Organized through BioCrossroads, Indiana,s initiative ...
(Date:12/16/2009)... company,s revenues increase 22% for fiscal 2009; on ... , TORONTO, Dec. 16 /PRNewswire-FirstCall/ - Microbix Biosystems ... and biological technologies, today reported financial results for ... year ended September 30, 2009, Microbix reported revenues ... same period in 2008. For fourth-quarter 2009, the ...
(Date:12/16/2009)... conducted pursuant to Special Protocol Assessment with ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris ... (the "Company"), a global biopharmaceutical company focused ... the initiation, by its partner Keryx Biopharmaceuticals ... 3 registration clinical trial for perifosine (KRX-0401), ...
(Date:12/16/2009)... December 16 Eppendorf has initiated ... Verigene(R) SP systems for,infringement of European patent ... for the,identification and/or the quantification of a ... all imports of the respective products into ... are required to confiscate any,violating products. , ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2
... BIRMINGHAM, Ala., June 18 BioCryst,Pharmaceuticals (Nasdaq: ... MB,BS, has been appointed Chief Medical Officer of ... seasoned biotechnology professional, most recently,serving as Vice President ... replaces interim Chief Medical Officer Dr. Tom Simon, ...
... excellence by ... communications professionals, WEST ... interactive marketing agency serving the healthcare,industry, announced today that ... Annual Communicator Awards. The Communicator Awards is the leading,international ...
... and Investment Banker Enhances ... EntreMed,s Senior Management Team, ROCKVILLE, Md., June ... company developing,therapeutics for the treatment of cancer and inflammatory diseases, ... Senior Vice,President, Corporate and Business Development. Mr. Bliss has been ...
Other Biology Technology:William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 2William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 3William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 4Cadient Group Recognized with Five Awards at 14th Annual Communicator Awards 2Cadient Group Recognized with Five Awards at 14th Annual Communicator Awards 3EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development 2EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development 3EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development 4
(Date:12/15/2009)... an agreement with the British Society for Research on ... journal Biogerontology for an initial period of ... of the Biogerontology editorial board and will ... will sponsor the society and provide society members with ... www.springerlink.com . , Biogerontology offers a platform ...
(Date:12/15/2009)... and ancient American horses may have been grazing ... longer than previously thought. After plucking ancient DNA ... of researchers used cutting-edge techniques to uncover "genetic ... dated to between 7,600 and 10,500 calendar years. ... population of these now-extinct mammals endured longer in ...
(Date:12/15/2009)... near future, consumers can look forward to ultra-low ... laptops, PDAs and mobile phones. This is made ... technologies which are critical elements for power optimisation ... systems. , Analog IC design is the key ... To pre-position the nation in advanced analog and ...
Breaking Biology News(10 mins):Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3New treatment in sight for ovarian cancer 55732 1New treatment in sight for ovarian cancer 55732 2Family stability may be more crucial than 2 parents for child success 55729 1Family stability may be more crucial than 2 parents for child success 55729 2Family stability may be more crucial than 2 parents for child success 55729 3Open source DNA 55727 1
... Library of Science - Biology papers have tons of images ... sure to check them out. Links at the bottom of ... a new tool to track and videotape cells moving about ... revealed, for example, the dramatic difference between the random wanderings ...
... developed at the Department of Energy's Pacific Northwest National ... of life -- bringing us one step closer to ... and protecting the country against biological threats. , ScalaBLAST ... the work of analyzing biological data into manageable fragments ...
... to Mexico, monarch butterflies are known to use the ... help them keep to a straight and true path ... a mystery. , Now, researchers, led by Steven Reppert ... the Czech Academy of Sciences and Adriana Briscoe of ...
Other Biology News:New tool reveals secrets of migrating cells 2New tool reveals secrets of migrating cells 3New tool reveals secrets of migrating cells 4New tool reveals secrets of migrating cells 5Genomic sequences processed in minutes, rather than weeks 2How monarch butterflies are wired for navigation 2
When added to StemSep T Cell Enrichment cocktail, human TCRab TAC is designed to deplete human TCRab from samples to isolate gd T cells....
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD45RA TAC is designed to deplete human CD45RA from samples to isolate memory CD4+ or CD8+ T cells....
... 'SoftLinx software, a multitasking application capable ... the programming and operation of lab automation ... enough for custom modification by programmers. ... a simple drag-anddrop flowchart. If you can ...
No-Weigh Dithiothreitol (DTT) ,7.7 mg DTT/Tube x 48 tubes...
Biology Products: